Organisation paid for research Program year 2025 Source: CMS Open Payments

Urologic Consultants

Neither a doctor nor a teaching hospital

Research payments

$92,293

9 payments

Through program year 2025, Urologic Consultants is reported as receiving $92,293 in research payments, across 9 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$15,734	1
2024	Research	$2,925	1
2023	Research	$30	1
2021	Research	$45	1
2020	Research	$55,106	1
2019	Research	$18,452	4

Breakdown

Who paid Research payments · program years 2019–2025

E.R. Squibb & Sons, L.L.C. $71,646 4 payments
Janssen Research & Development, LLC $20,646 5 payments

Studies the money was for Research payments · program years 2019–2025

Phase IIB NMI Bladder BCG Unresponsive Nivo or Nivo IDO $71,616 3 payments
A Multi Center Randomized Double Blind Placebo Controlled Phase III Study of ARN509 in Men With Non Metastatic M0 Castration Resistant Prostate Cancer $18,659 2 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer $1,987 3 payments
Phase IIB NMI Bladder BCG Unresponsive Nivo or Nivo+IDO $30 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.